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Abstract: Chronic obstructive pulmonary disease (COPD) is the third leading cause of death globally
and ozone exposure is a main cause of its disease burden. However, studies on COPD hospitalizations
from short-term ambient level ozone exposure have not generated consensus results. To address
the knowledge gap, comprehensive and systematic searches in several databases were conducted
using specific keywords for publications up to February 14, 2020. Random-effect models were
used to derive overall excess risk estimates between short-term ambient-level ozone exposure and
COPD hospitalizations. The influence analyses were used to test the robustness of the results. Both
meta-regression and subgroup analyses were used to explore the sources of heterogeneity and
potential modifying factors. Based on the results from 26 eligible studies, the random-effect model
analyses show that a 10 µg/m3 increase in maximum 8-h ozone concentration was associated with
0.84% (95% CI: 0.09%, 1.59%) higher COPD hospitalizations. The estimates were higher for warm
season and multiple-day lag but lower for old populations. Results from subgroup analyses also
indicate a multiple-day lag trend and bigger significant health effects during longer day intervals.
Although characteristics of individual studies added modest heterogeneity to the overall estimates,
the results remained robust during further analyses and exhibited no evidence of publication bias.
Our systematic review and meta-analysis indicate that short-term ambient level ozone exposure was
associated with increased risk of COPD hospitalizations. The significant association with multiple-day
lag trend indicates that a multiple-day exposure metric should be considered for establishing ambient
ozone quality and exposure standards for improvement of population health. Future investigations
and meta-analysis studies should include clinical studies as well as more careful lag selection protocol.
Keywords: ozone; chronic obstructive pulmonary disease; environmental health; meta-analysis
1. Introduction
Chronic obstructive pulmonary disease (COPD), which is characterized by progressive and
irreversible airflow limitation and chronic inflammation of the lungs, is the third leading cause of
death globally [1]. According to the Global Burden of Disease (GBD) Study 2015 [2], exposures to
ambient particulate matter and ozone have been ranked as the second and fifth biggest causes of COPD,
respectively. Although the relationship between ambient particulate matter and COPD has been widely
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investigated [3–6], that for ozone is less extensive and the results are less consistent [7,8]. In the 2006
Air Quality Criteria for Ozone report [9], the association between short-term ozone exposure and
respiratory effects has been emphasized, but this is based mainly on epidemiological studies regarding
total respiratory diseases and/or asthma, not specifically on COPD. Since then, studies based on ozone
exposure and hospital admissions have been increasingly investigated. For example, several valuable
studies which were conducted in Iran [10], Italy [11], France [12] have also put further insight into
this field.
Meta-analysis is an important approach to synthesizing evidence across studies. So far, four
analyses have been conducted to quantify the association between short-term ambient ozone exposure
and COPD hospitalizations [13–16] (Table S1): one was focused solely on East Asia [13], one was based
on publications before 2008 [14], and the other two, conducted in 2015 [15] and 2016 [16], simply reported
pooled risk estimates. Since then, several original investigations have been published [17–20]. In
addition, a major issue has been raised regarding exposure to other air pollutants simultaneously, which
may confound ozone-related effect estimates [21]. Indeed, there has not been another meta-analysis to
summarize the more recent publications and address impacts from exposure to co-pollutants. The lack
of an updated meta-analysis and pooled risk estimates would limit the ability to fully understand the
impact of ambient level ozone exposure on COPD development.
To provide an updated and better understanding of the association between short-term ambient
ozone exposure and COPD hospitalizations, a systematic review and meta-analysis were conducted
with strict inclusion/exclusion criteria and with attention to the source of effect variations.
2. Material and Methods
2.1. Search Strategy
With no start date specified, four literature databases (PubMed, Web of Science, Medline and
Embase) were searched for publications in English before September 19, 2019. The search was
further updated in February 14, 2020. Keywords used included “chronic obstructive pulmonary
disease,” “COPD,” “ozone,” and “O3”, alone and in combination. After excluding duplications using
NoteExpress, the titles and abstracts from the publications were reviewed. The potentially eligible ones
were selected and retrieved as full texts. Furthermore, references in previous meta-analysis papers
were screened for any pertinent articles that were not previously identified. Finally, the acquired
articles were reviewed and filtered according to the inclusion and exclusion criteria.
Selection of publications was undertaken independently by two of the authors (H.G. and K.W.).
Afterwards, the two authors discussed their results and disagreements were settled by consensus. A
flow diagram for details of the search process in the meta-analysis is given in Figure 1.
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Figure 1. Study selection flowchart (searching before September 19, 2019). 
2.2. Inclusion Criteria 
The criteria were: (1) original studies; (2) study design: case crossover or time series; (3) reliable 
exposure measurement: ozone exposure was estimated by research grade methods or national 
monitoring station, reported with no missing or only a few missing days; (4) COPD definition: the 
International Classification of Disease (ICD), Ninth or Tenth Revision; (5) clear outcome 
measurements: studies reported quantitative measures of association, or gave sufficient data to 
calculate the excess risk (ER) and 95% CI; (6) results evaluated the influence of short-term exposure 
to ambient ozone. 
2.3. Exclusion Criteria 
The criteria were: (1) incomplete information; (2) non-observational study design; (3) non-
original studies; (4) did not provide calculable or reported ER/relative risk (RR)/odds ratio 
(OR)/percent change and 95% CI; (5) uncertain diagnosis of COPD, or diagnosis according to 
pulmonary function test; (6) patients with COPD and asthma, or did not mention whether asthma 
was excluded. 
  
Figure 1. Study selection flowchart (searching before September 19, 2019).
2. . Inclusion Criteria
The criteria were: (1) original studies; (2) study design: case crossover or time series; (3) reliable
exposure measurement: ozone exposure was estimated by research grade methods or national
monitoring station, reported with no missing or only a few missing days; (4) COPD definition: the
International Classification f Disease (ICD), Ninth or Te t Revisio ; (5) clear outcome measurements:
studies r ported quantitative m asures of ssociation, or gave ufficient data to calc late the excess
risk (ER) and 95% CI; (6) results evaluated the infl enc of short-term exposure to ambient ozone.
2.3. Exclusion Criteria
The criteria were: (1) incomplete information; (2) non-observational study design; (3) non-original
studies; (4) did not provide calculable or reported ER/relative risk (RR)/odds ratio (OR)/percent change
and 95% CI; (5) uncertain diagnosis of COPD, or diagnosis according to pulmonary function test; (6)
patients with COPD and asthma, or did not mention whether asthma was excluded.
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2.4. Data Extraction
The following data from the eligible publications were extracted: first author, year of publication,
study location, study design, study period, assessment of ambient ozone exposure, characteristics
of temperature, detailed definition of outcome, data source (emergency department visits/hospital
admissions), pollutant model, confounding factors, and statistical model. Data on effect estimates
(single-pollutant and multi-pollutant models) of the association (and their 95% CI) between ambient
ozone exposure and COPD hospitalizations were also extracted.
The data extraction process was also undertaken independently by two of the authors (H.G. and
K.W.) and disagreements were settled by consensus. The characteristics of the included studies [17–20,
22–43] are shown in Tables S1, S2, and S3.
2.5. Risk-of-Bias Assessment
Although researchers have suggested to evaluate the quality of time series or case
crossover studies [44], there were still no validated scales recommended [45]. Unlike previous
meta-analyses [15,16] which just assessed the risk-of-bias or quality subjectively, based on exposure
assessment, outcome definition, adjustments of cofounders, etc., our study involved an initial search
based on more strict inclusion/exclusion criteria (see above). This also explains why the number
of included publications in our study is relatively smaller than the previous meta-analyses. After
excluding unqualified studies, the quantitative meta-analysis in our study was performed using data
collected from homogeneous backgrounds (see below). Thus, the specific risk-of-bias assessment
services were not needed here.
2.6. Data Synthesis
Excess risk (ER, %) was pooled from appropriate studies per 10 µg/m3 increment in ambient
maximum 8-h ozone concentration. This metric has been reported as closely associated with respiratory
health [46]. However, for the study that reported results using a different exposure metric, other
methods were used: estimates were based on maximum 8-h average ozone concentration or converted
from other metrics by a standard ratio, a relationship of 20: 15: 8 for 1-h maximum: maximum
8-h average: 24-h average [47]. Our assumption was that 1 ppb equals 1.96 µg/m3, which would
ensure comparable units. The OR or RR was also converted to ER in accordance with a previous
study [48]. Briefly, considering that the increased risk of COPD hospitalizations would be very low,
the measurements of OR and RR would be almost equivalent. Therefore, a transformation formula
was used:
ER =
(
e
ln (RR∗)
IQR ×10 − 1
)
× 100% (1)
where RR∗ and IQR were the relative risk and exposure metrics used in the original study.
Some studies reported multiple estimates as several lagged days, age groups, seasons, or other
factors. Considering the bias that age [40], temperature [47], co-pollutants [49], or lag [14] might have
caused, it was necessary to include only one estimate from each study with the shortest lag for all ages,
all years, and without adjustment for co-pollutants for the calculation of overall excess risk estimates,
except when a single study provided results from different temperature levels or multicity results.
Each temperature-specific or city-specific result would be included. The same chosen standard was
also used to pool the level-specific estimate during the subgroup analyses, except for the level explored
in our study.
2.7. Statistical Methods
Due to different study designs, methods of analysis, different lag exposures, geographical and
population differences, and experiences from previous studies [14,44,50], heterogeneity between studies
was anticipated and a random-effect model was used to account for both within- and between- study
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heterogeneity. The standard I2 test was used to examine the heterogeneity. A funnel plot and an Egger
test were used to investigate publication bias.
Influence analyses were performed using both covariance ratio and hat plots to identify possible
influential cases [51]. After excluding influential cases, “leave-one-out” analyses were performed to
test the robustness of our results. Meta-regression was used to investigate the possible modification
effects of publication year, study location, study design, data source, definition of outcome and
influenza-adjusted status on the overall effect sizes of ozone, which would provide more information
on the source of the heterogeneity among the included studies. Furthermore, subgroup analyses were
performed to investigate how estimates differed by age, temperature, lag structure and co-pollutants.
All statistical analyses were performed with the R software, version 3.6.1 (R Foundation for
Statistical Computing, Vienna, Austria), using the “meta” “metafor” “dmetar” and “forestplot”
packages. A p value of less than 0.05 was considered to indicate statistical significance.
This meta-analysis was conducted in accordance with Preferred Reporting Items for Systematic
review and Meta-Analyses (PRISMA) guidelines [52].
3. Results
3.1. Search Findings and Study Characteristics
The initial literature searches yielded 1998 documents (PubMed: 231; Web of Science: 241; Medline:
1073; Embase: 449; Other Source: 4), of which 1976 were excluded based on duplication, title and
abstract, and full text review. Therefore, 26 original articles were selected for further analyses.
Table 1 provides an overview of all the included studies, 19 were time series studies, while 7 were
case crossover studies. Most studies were conducted in North America, Europe, and China. Nearly
half of the eligible studies adjusted for influenza effects in their reported results. Most studies used
the ICD-9 COPD definition. Additionally, Table S2 provides detailed information about study period,
COPD definition and the characteristics of ambient ozone level and temperature for the included
studies, while Table S3 provides a summary of the adjusted confounders and statistical models used.
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Table 1. Contextual details of studies included in the meta-analysis.
Author Location Published Period Study Design Data Source Population Definition ofOutcome Influenza
Malig et al. USA 2016 2005–2008 Case crossover EDVs All ICD-9 Adjust
Pothirat et al. Thailand 2019 2016–2017 Time series EDVs & HAs All ICD-10 No
Szyszkowicz et al. Canada 2018 2004–2011 Case crossover EDVs ≥55 years ICD-10 Adjust
Lee et al. China 2007 1996–2003 Case crossover HAs All ICD-9 No
Fusco et al. Italy 2001 1995–1997 Time series HAs All ICD-9 Adjust
Schwartz et al. USA 1994 1986–1989 Time series HAs ≥65 years ICD-9 No
Morgan et al. Australia 1998 1990–1994 Time series HAs ≥65 years ICD-9 No
Tenias et al. Spain 2002 1994–1995 Time series EDVs ≥14 years ICD-9 No
Peel et al. USA 2005 1993–2000 Time series EDVs All ICD-9 Adjust
Liang et al. China 2019 2013–2017 Time series HAs ≥18 years ICD-10 No
Reid et al. USA 2019 2008 Time series EDVs & HAs All ICD-9 No
Yang et al. Canada 2005 1994–1998 Time series EDVs ≥65 years ICD-9 No
Halonen et al. Finland 2010 1998–2004 Time series EDVs & HAs ≥65 years ICD-10 Adjust
Anderson et al. UK 2001 1994–1996 Time series HAs ≥65 years ICD-9 Adjust
Qiu et al. China 2013 1998–2007 Time series EDVs All ICD-9 Adjust
Dab et al. France 1996 1987–1992 Time series HAs All ICD-9 Adjust
Ko et al. China 2007 2000–2004 Time series EDVs All ICD-9 No
Hinwood et al. Australia 2006 1992–1998 Case crossover HAs All ICD-9 No
Arbex et al. Brazil 2009 2001–2003 Time series EDVs ≥40 years ICD-10 No
Ding et al. China 2017 2000–2013 Case crossover EDVs 65–79 years ICD-9 No
Yang et al. China 2007 1996–2003 Case crossover HAs All ICD-9 No
Schouten et al. Netherlands 1996 1977–1989 Time series EDVs All ICD-9 Adjust
Strosnider et al. USA 2018 2000–2014 Time series EDVs ≥19 years ICD-9 No
Anderson et al. Europe 1997 1977–1992 Time series EDVs All ICD-9 Adjust
Stieb et al. Canada 2009 1992–2003 Time series EDVs All ICD-9/ICD-10 No
Medina-Ramon et al. USA 2006 1986–1999 Case crossover HAs ≥65 years ICD-9 No
Note: EDVs, emergency department visits; HAs, hospital admission visits.
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3.2. Ambient Level Ozone Exposure and COPD Hospitalizations
A total of 15 studies with 20 estimates were used to pool overall ER between short-term
ambient level ozone exposure and COPD hospitalizations in all age-range and year-round exposure.
As illustrated in Figure 2, results from the random-effect model show that a 10 µg/m3 increase
in maximum 8-h ozone concentration was associated with 0.84% (95% CI: 0.09%, 1.59%) higher
COPD hospitalizations.
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3.3. Publication Bias
The Egger test and funnel plot were used to investigate publication bias. The funnel plot analyses
did not reveal asymmetry results (Figure S4). The estimates based on the Egger test (bias = 1.32,
p = 0.336) further suggest that publication bias did not exist in the overall effect estimate. When the
influential case was excluded, the results from the funnel plot and the Egger test (Figure S5. bias = 1.12,
p = 0.444) remained robust.
3.4. Heterogeneity by Meta-Analysis
Meta-regression analyses were used to investigate potential sources of heterogeneity, according to
a set of key study characteristics including publication year, study design, study location, definition
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of outcome, data source and influenza. The results indicate that all these factors contributed to the
heterogeneity (data not shown). The results from the study design show modifying effects at the
borderline significant level (Figure S6. β = −1.52, p = 0.061), which gained significance after the
influential case was removed (Figure S7. β = −1.67, p = 0.010).
3.5. Subgroup Analyses
Subgroup analyses were conducted to explore the effects of age, season, co-pollutants and lag
structure. To untangle complicated effects among different factors, only estimates from all age-range
and year-round exposure were used to calculate the pooled results for co-pollutants and different lag
structures. In addition, year-round exposure data were used to investigate the effect of age and all age
ranges, to explore seasonal variations.
As illustrated by Figure 3, the effect size was weaker among the older population (0.27% 95% CI:
−0.02%, 0.57%). This borderline effect, however, lost its significance (0.30% 95% CI: −0.13%, 0.73%)
after the estimates from Ding’s study [39] which provided results for different temperature levels, were
removed from our analyses. A significant effect was found during the warm but not the cold season,
with an increment of 1.06% (95% CI: 0.26%, 1.87%) in COPD hospitalizations per 10 µg/m3 increase
in maximum 8-h ozone level. As for the different lag structures (Figure 4), the single-day lag results
generally showed insignificant and lower pooled results, while the multiple-day lag gained statistical
significance with bigger effect estimates during longer day intervals.
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4. Discussion
These 26 carefully selected publications provided sufficient data for our systematic review
and meta-analysis to investigate the relationship between short-term ozone exposure and COPD
hospitalizations. Of all the air pollutants, ozone is expected to have the strongest correlation with both
temporal and meteorological factors, thus only studies with both variables adjusted were used in our
analyses. Considering the confounding effects from age and season, subgroup excess risk was estimated
only from all age-range populations and year-round ozone exposure. Our analyses demonstrate that,
after short-term exposure, each 10 µg/m3 increase in the maximum 8-h ozone concentration was related
to a 0.84% (95% CI: 0.09%, 1.59%) increase in COPD hospitalizations. The overall effect size detected in
our study is relatively smaller than that in previous meta-analysis, which could be due to our more
stringent criteria for effect data extraction.
Meta-regression analyses were used to investigate effect modifiers for overall risk estimates. The
analyses show that study designs contributed to borderline significant modifications on health effects
from ozone exposure. However, this could be a chance finding, because the differential effects of case
crossover design came mainly from two studies. From our analyses, no significant modifying effect
was observed for influenza-adjusted status, while Wong et al. [53] found that when the influenza
intensity increased from 0% to 10%, the excess risk per 10 µg/m3 increase in ozone level increased
0.40% for COPD hospitalizations in the ≥ 65 age group. This heterogeneity could be due to the limited
statistical power of the small sample size for our meta-analysis and the relatively low modifying
effects. Although insignificant modifying effects were found for different data sources, it should be
emphasized that, when examining the association between air pollution exposure and respiratory
health effects that require medical attention, it is important to distinguish between hospital admissions
and emergency department visits. This is because only a small percentage of respiratory emergency
department visitors are admitted to hospitals. Therefore, emergency department visits (especially by
self-referrals) may represent less serious but more common outcomes [14].
Results from our subgroup analyses suggest that age and seasonal variations existed. Consistent
with findings from previous studies [41,47], stronger associations were found during the warm season,
which can be explained by the following: (a) ozone concentrations are typically higher during the warm
season; (b) individuals tend to engage in more outdoor activities during the warm season, resulting in
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even higher exposure levels. As for the relatively weak effects estimated among the old-age group,
the result is also consistent with a similar meta-analysis [14] and a multicity study [40]. A previous
weight-of-evidence study [21], based on mortality data, concluded that the elderly were at high
respiratory health risk from short-term ozone exposure, but the result was inconsistent with morbidity
evidence [40]. Unlike asthma or other respiratory diseases, the nature and sites of inflammation
among COPD patients are quite different and may be related to different responses to environmental
pollutants [54]. Therefore, COPDs may have a different pathology and different clinical manifestations
from other respiratory diseases. In addition, symptomatic responses, such as cough or shortness of
breath, to ozone exposure tend to increase with age until early adulthood, and then gradually decrease
with increasing age [9]. This could influence the effect estimates for the old-age group because they are
more tolerant to high ozone pollution.
To our knowledge, this is the first meta-analysis and systematic review which has addressed the
differences by lag selection and co-pollutants. Our co-pollutant subgroup analyses included estimates
only from the all-age-range populations and from year-round ozone exposure, to avoid further
confounders. Although the numbers of estimates were not large, our results demonstrate that short-term
ozone exposure was positively associated with COPD hospitalizations, using co-pollutants-adjusted
data. Our study also identified meaningful results from different lag subgroups. Many previous
studies reported have observations for the lag with the most statistically significant results, instead
of all lag structures, but this would bias estimates upward. However, if associations were observed
in a multiple-day lag selection but not in a single-day lag selection, single-day lag investigations
may underestimate the effects, which is well demonstrated in our results. Indeed, the single-day lag
results generally show insignificant and lower pooled results, while the multiple-day lag results show
statistical significance with bigger effect estimates during longer day intervals.
Current short-term ambient ozone quality standards for most countries are solely based on daily
maximum 8-h exposure concentrations [55]; our results indicate that multiple-day averages should also
be considered. However, our ability to analyze trends in even longer time intervals was limited, because
most studies did not report results of all lag structures. It is quite likely that the cumulative effects
we found were in existence within three days, which is strongly indicated in previous ozone-related
mortality studies [47,56]. Our results also indicate that the lag selection protocol might bias the pooled
results when performing meta-analyses of ozone-related epidemiological studies. Whether this lag
selection bias exists in other air pollution meta-analyses remains unknown.
Several limitations should be considered here. In most of the selected studies, confounding factors
were adjusted differently to each other, which might lead to bias. However, as all the selected studies
were controlled for the crucial confounders, for example, temperature, relative humidity, day of week,
and long-term factors for the time-series, the limitations would not cause a significant impact on our
results. Additionally, the subgroup results are based on relatively small numbers of selected studies.
More studies are needed to verify our results.
5. Conclusions
In summary, our results show that short-term ambient ozone exposure was positively associated
with COPD hospitalizations and no publication bias was found. The subgroup analyses indicate that
the relationship might vary among different age ranges and seasons. The multiple-day lag trend, with
more significant effect estimates during longer day intervals, indicates that a multiple day exposure
metric needs to be considered for establishing ambient ozone quality standards. However, this lag trend
still needs further investigation. Future environmental studies and meta-analyses, which investigate
the health effects of short-term ozone exposure, should also consider a lag selection protocol.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/17/6/2130/s1,
Table S1: Summary of former meta-analysis articles about short-term ambient level ozone exposure and COPD
hospitalizations, Table S2: Summary of study location, study period, ICD codes and weather, Table S3: Summary of
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